We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15... Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Show more
MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss...
Trump Media & Technology Group (NASDAQ:DJT) – Donald Trump’s media company reported a $19.2 million loss in Q3, driven by $12.1 million in legal fees tied to a streaming deal and SPAC...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -21.23 | -19.781960492 | 107.32 | 109.88 | 84.93 | 5128116 | 106.53914664 | CS |
4 | -18.03 | -17.3165578179 | 104.12 | 112.52 | 84.93 | 4887491 | 107.85039547 | CS |
12 | -34.46 | -28.5856491083 | 120.55 | 121.34 | 84.93 | 5271620 | 110.39869598 | CS |
26 | -55.53 | -39.2105634797 | 141.62 | 148.15 | 84.93 | 4513246 | 121.01676707 | CS |
52 | -15.11 | -14.9308300395 | 101.2 | 148.15 | 84.93 | 4452775 | 122.36884589 | CS |
156 | 34.025 | 65.3510035533 | 52.065 | 148.15 | 45.755 | 2761283 | 100.70874217 | CS |
260 | 57.08 | 196.759738021 | 29.01 | 148.15 | 24.62 | 2138663 | 86.03849418 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions